Aptrocit P 500mg/800mg Tablet
Marketer
HS Aldem Healthcare
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Aptrocit P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive enhancement. It safeguards brain cells from injury and promotes their repair, finding application in treating brain trauma as well. NeuroMend can be ingested with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's dosage and duration instructions precisely. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even with symptom improvement; abruptly ceasing treatment requires prior consultation to avoid potential symptom exacerbation. Common, typically transient side effects include restlessness, abdominal discomfort, anxiety, and hypotension. If these persist or are troubling, seek medical advice. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; counter this through a healthy diet and regular physical activity.
Primary Ingredients of Aptrocit P 500mg/800mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Aptrocit P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Aptrocit P 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Aptocit P 500mg/800mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Aptrocit P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Aptrocit P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Aptrocit P 500mg/800mg tablet whole; avoid chewing, crushing, or breaking it. It can be administered with or without food, although consistent timing is recommended.
How Aptrocit P 500mg/800mg Tablet works:
Aptrocit P 500mg/800mg tablets contain citicoline and piracetam, two neuroprotective agents. Citicoline supports neuronal health by fostering cell nourishment, shielding against damage, and enhancing cell viability. Piracetam, a GABA analogue, offers brain and nervous system protection against hypoxia and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Aptrocit P 500mg/800mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Aptrocit P 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Aptrocit P 500mg/800mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Aptrocit P 500mg/800mg tablets might lead to adverse effects, including drowsiness and tremor, potentially impairing driving skills.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Aptrocit P 500mg/800mg tablets, potentially requiring dosage modification. Medical advice is recommended. Aptrocit P 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Aptrocit P 500mg/800mg tablets in patients with liver disease is likely safe. Preliminary findings indicate dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Aptrocit P 500mg/800mg Tablet :
Should you forget to take your Aptrocit P 500mg/800mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Aptrocit P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |





